Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Correction to: Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.
Journal: World journal of urology
Published: November 03, 2025
Primary Bladder Neck Obstruction in Women: A Systematic Review.
Journal: Current urology reports
Published: June 10, 2025
Outcomes of Hyperbaric Oxygen Therapy at 2.0 Versus 2.5 ATA for Hemorrhagic Radiation Cystitis.
Journal: Neurourology and urodynamics
Published: May 28, 2025
Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.
Journal: World journal of urology
Published: May 23, 2025
Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: March 28, 2025
Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder.
Journal: Neurourology and urodynamics
Published: March 16, 2025
Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.
Journal: Toxins
Published: March 13, 2025
The Role of Urodynamics in Assessing Lower Urinary Tract Symptoms Post-Radical Prostatectomy: A Review.
Journal: Neurourology and urodynamics
Published: January 17, 2025
Predictors of Care-Seeking Behavior for Treatment of Urinary Incontinence in Men.
Journal: Lower urinary tract symptoms
Published: November 24, 2024
Impact of Gender Affirming Vaginoplasty on Lower Urinary Tract Function: A Single-Center Prospective Cohort Study.
Journal: Neurourology and urodynamics
Published: September 07, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.
Journal: Toxins
Published: August 29, 2024
A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause.
Journal: Menopause (New York, N.Y.)
Published: July 23, 2024
Last Updated: 09/26/2026